公司資料
QAthersys, Inc. 股價、新聞與催化劑
- 股票代碼:
- ATHX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for ATHX.
公司概覽
業務概覽
Athersys was a regenerative medicine company focused on cell therapy and acute inflammatory conditions before becoming a historical biotech name. Its story revolved around stem-cell science and the challenge of moving it into a practical treatment.
所在地與產業分類
Athersys was headquartered in the United States and listed on NASDAQ. It sat in regenerative medicine and biotechnology.
商業模式特徵
The company depended on clinical proof, manufacturing feasibility, and a constant need for financing. Investors historically followed readouts, strategic shifts, and whether the platform could survive long enough to scale.
生技產業定位
Athersys occupies the historical regenerative-medicine bucket. Like many cell-therapy developers, it was highly sensitive to capital and clinical execution.
未來催化劑
- Athersys is largely a legacy / closeout story now, with catalysts limited to any strategic or asset-resolution update. The market is mainly focused on what remains after the restructuring.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。